Cargando…
Patient Involvement in the Health Technology Assessment Process in Taiwan
The COVID-19 pandemic initially had a smaller impact on Taiwan than on most other industrialized countries. However, an outbreak in late April 2021 led to a sharp surge in cases from mid-May 2021. Patient involvement in the health technology assessment (HTA) process, however, was not much affected b...
Autores principales: | Chen, Kuei An, Huang, Li Ying, Gau, Churn Shiouh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814514/ https://www.ncbi.nlm.nih.gov/pubmed/35128522 http://dx.doi.org/10.3389/fmedt.2021.732160 |
Ejemplares similares
-
The impact of the rare disease and Orphan Drug Act in Taiwan
por: Hsiang, Ning-Chun, et al.
Publicado: (2021) -
Where National Medicines Policies Have Taken Us With Patient Involvement and Health Technology Assessment in Africa
por: Sehmi, Kawaldip, et al.
Publicado: (2022) -
Editorial: Where to from here: Advancing patient and public involvement in health technology assessment (HTA) following the COVID-19 pandemic
por: Wale, Janet L., et al.
Publicado: (2023) -
Can We Afford to Exclude Patients Throughout Health Technology Assessment?
por: Wale, Janet L., et al.
Publicado: (2022) -
Epidemiology, clinical profile and treatment patterns of venous thromboembolism in cancer patients in Taiwan: a population-based study
por: Chew, Tan-Wei, et al.
Publicado: (2015)